These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20941557)

  • 1. Allergic reactions to clopidogrel and cross-reactivity to other agents.
    Lokhandwala J; Best PJ; Henry Y; Berger PB
    Curr Allergy Asthma Rep; 2011 Feb; 11(1):52-7. PubMed ID: 20941557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clopidogrel desensitization: case report and review of published protocols.
    Owen P; Garner J; Hergott L; Page RL
    Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of clopidogrel hypersensitivity without drug interruption.
    Campbell KL; Cohn JR; Fischman DL; Walinsky P; Mallya R; Jaffrani W; Savage MP
    Am J Cardiol; 2011 Mar; 107(6):812-6. PubMed ID: 21247516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel.
    Lokhandwala JO; Best PJ; Butterfield JH; Skelding KA; Scott T; Blankenship JC; Buckley JW; Berger PB
    Circ Cardiovasc Interv; 2009 Aug; 2(4):348-51. PubMed ID: 20031738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of prasugrel in a patient with clopidogrel hypersensitivity.
    Peppard SR; Held-Godgluck BM; Beddingfield R
    Ann Pharmacother; 2011 Oct; 45(10):e54. PubMed ID: 21896923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prasugrel in the setting of clopidogrel hypersensitivity: Case report and systematic review of the literature.
    Siu H; Kaliyadan A; Fischman DL; Nardone E; Poll D; Savage MP
    Platelets; 2016 Dec; 27(8):824-827. PubMed ID: 27494368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prasugrel use in a patient allergic to clopidogrel: effect of a drug shortage on selection of dual antiplatelet therapy.
    Felix-Getzik E; Sylvia LM
    Am J Health Syst Pharm; 2013 Mar; 70(6):511-3. PubMed ID: 23456404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clopidogrel desensitization after drug-eluting stent placement.
    von Tiehl KF; Price MJ; Valencia R; Ludington KJ; Teirstein PS; Simon RA
    J Am Coll Cardiol; 2007 Nov; 50(21):2039-43. PubMed ID: 18021870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity.
    Walker NE; Fasano MB; Hobbs RA; Horwitz PA
    Crit Pathw Cardiol; 2007 Mar; 6(1):26-9. PubMed ID: 17667884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing Allergist and Cardiologist Considerations for the Optimal Management of Thienopyridines Hypersensitivity.
    Calogiuri G; Mandurino-Mirizzi A; Parlangeli C; Macchia L; Foti C; Savage MP
    Endocr Metab Immune Disord Drug Targets; 2019; 19(1):2-12. PubMed ID: 30215337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR).
    Jacob S; Dunn BL; Qureshi ZP; Bandarenko N; Kwaan HC; Pandey DK; McKoy JM; Barnato SE; Winters JL; Cursio JF; Weiss I; Raife TJ; Carey PM; Sarode R; Kiss JE; Danielson C; Ortel TL; Clark WF; Rock G; Matsumoto M; Fujimura Y; Zheng XL; Chen H; Chen F; Armstrong JM; Raisch DW; Bennett CL
    Semin Thromb Hemost; 2012 Nov; 38(8):845-53. PubMed ID: 23111862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of clopidogrel hypersensitivity reactions and management with oral steroids without clopidogrel discontinuation.
    Cheema AN; Mohammad A; Hong T; Jakubovic HR; Parmar GS; Sharieff W; Garvey MB; Kutryk MJ; Fam NP; Graham JJ; Chisholm RJ
    J Am Coll Cardiol; 2011 Sep; 58(14):1445-54. PubMed ID: 21939827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
    Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
    Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clopidogrel (Plavix) desensitization: a case series.
    Camara MG; Almeda FQ
    Catheter Cardiovasc Interv; 2005 Aug; 65(4):525-7. PubMed ID: 15973671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of Clopidogrel Hypersensitivity: The Jefferson Approach.
    Vishnevsky A; Savage MP; Fischman DL
    Curr Vasc Pharmacol; 2019; 17(2):123-126. PubMed ID: 30058491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization for the management of clopidogrel hypersensitivity: initial clinical experience.
    Walker NE; Fasano MB; Horwitz PA
    J Invasive Cardiol; 2006 Jul; 18(7):341-4. PubMed ID: 16816444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report on clopidogrel rash after coronary placement of a paclitaxol-coated stent.
    Satish B; Tressa K; Harish CR
    Crit Pathw Cardiol; 2007 Mar; 6(1):24-5. PubMed ID: 17667883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel hypersensitivity syndrome with rash, fever, and neutropenia.
    Doogue MP; Begg EJ; Bridgman P
    Mayo Clin Proc; 2005 Oct; 80(10):1368-70. PubMed ID: 16212151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen.
    Fajt M; Petrov A
    Ann Pharmacother; 2010 Jan; 44(1):11-8. PubMed ID: 20009004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ticagrelor as an alternative in clopidogrel-associated neutropenia.
    Shah R; Keough LA; Belalcazar-Portacio A; Ramanathan KB
    Platelets; 2015; 26(1):80-2. PubMed ID: 24433137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.